COVER FOCUS ARE YOU AN INNOVATOR? Evidence of emerging innovation in medical aesthetics. INVESTIGATIONAL ADAPTED HA GEL MAY REDUCE EYE CIRCLES CLINICAL TIP A new innovation in hyaluronic acid fillers may provide some benefit in the reduction of eye circles. An adapted HA gel made by Teoxane called Teosyal Redensity II, Advancing Skin Care already approved in the EU and Canada, but not approved In the foreseeable future, I see makeup and skin care by the FDA, has physical properties similar to soft HA. It manufacturers alike striving to create formulas that is composed of both cross-linked and non-cross-linked adapt to individual skin types. Science is on the verge HA in addition to amino acids and minerals. This creates a now of having the ability to develop moisturizers that product that reportedly lasts for an average of a year and, can sense what the skin needs—more or less moisture, no matter the quantity injected, has not been shown to for example. We will see this individual adaptation lead to any swelling or Tyndalling. Teosyal Redensity II’s becoming more important to consumers: self-tanners viscoelastic profile provides minimal pressure on tissues, and users of sunscreens and makeup. It won’t be long which offers an easy injection into a confined, narrow area, before one shade really can fit all. optimal spreading, and controlled positioning. Active ingredients that produce visible results are informing all areas of the cosmeceutical world, resulting FDA APPROVES NEW SILICONE GEL- in more investigation into stem cells and nutriceuticals. FILLED BREAST IMPLANT The US consumer has been slow to adopt the philoso- FDA approved the Natrelle 410 Highly Cohesive phy that what you put in your body can help the health Anatomically Shaped Silicone-Gel Filled Breast Implant of the skin, but I think that this will change as supple- (Allergan) for breast augmentation in women at least 22 ments become more effective and more targeted. years old and to reconstruct breast tissue in women of any —Jane Iredale, Jane Iredale Cosmetics age. FDA based its approval on seven years of data from Get the full story online at 941 women. Most complications and outcomes reflect PracticalDermatology.com. Search Key: Iredale those found in previous breast implant studies including capsular contracture, re-operation, implant removal, asym- metry, and infection. In addition, investigators observed fissures in the gel of some Natrelle 410 implants. Allergan’s studies did not compare the safety and effec- The silicone gel in the Natrelle 410 implant contains more tiveness of the Natrelle 410 implant to other previously cross-linking compared to the silicone gel used in Allergan’s approved silicone gel-filled breast implants on the market. previously approved Natrelle implant. This increased cross- Therefore, these implants cannot be directly compared to linking results in a firmer gel. Of note, the FDA noted that any previously FDA-approved implant. 32 MODERN AESTHETICS | MARCH/APRIL 2013 COVER FOCUS TRENDING NOW “Innovation is critical in meeting unmet needs of patients and is particu- larly relevant in the context of chang- ing healthcare systems...Protecting intellectual property is fundamental to the discovery of new medicines. The research-based pharmaceuti- cal industry is committed to working closely with the Indian Government and other stakeholders to find appro- priate solutions to this challenge.” ON DELEGATING —Statement from John Castellani, President and CEO of “I think if young women could learn that earlier, Pharmaceutical Research and Manufacturers of America that would be really helpful, because we’re taught (PhRMA), in response to the Indian Supreme Court’s ruling on Glivec patent protection. Full statement at PhRMA.org. from an early age that we need to do everything, and we need to do everything well, and we don’t nies will jointly invest and work together on a number of hand things to other people.” programs, including group purchasing and licensing; prac- —Heidi A. Waldorf, MD, FAAD tice management services and tools; and co-marketing/ public relations campaigns. Pursuant to the strategic part- nership agreement, ASPS will receive an equity investment in Strathspey Crown. n Get the full story at TV ModernAesthetics.tv MA Search Key: Delegating PLASTIC SURGERY FOUNDATION TO RECOGNIZE INNOVATION In order to foster the development of new technological innovations and inventions in cosmetic and reconstruc- tive plastic surgery, the Plastic Surgery Foundation (PSF) will award $5,000 to two top innovators. Winners of the new Technology Innovation in Plastic Surgery (TIPS) Innovation Challenge will be announced at the PSF’s TIPS meeting May 31-June 2, 2013 in San Francisco. In addition to the cash prize, winners will have an opportunity for mentorship from an expert panel of judges. L’Oreal continues to support scientific research through the L’Oreal-UNESCO For Women in Science program. Five women ASPS AND STRATHSPEY CROWN scientists from around the world received the 2013 L’Oreal- ANNOUNCE STRATEGIC PARTNERSHIP UNESCO Awards in the Physical Sciences at a ceremony March The American Society of Plastic Surgeons (ASPS) and 28 at Sorbonne University in Paris. Deborah Jin, PhD (second Strathspey Crown Holdings LLC, a lifestyle healthcare from left) of JILA, NIST, and the University of Colorado was hon- growth equity firm, have signed a strategic partnership ored as the 2013 Laureate for North America. agreement designed to assist plastic surgeons. The compa- MARCH/APRIL 2013 | MODERN AESTHETICS 33 .